Brian Cook, P.A.-C

NPI: 1932381696
Total Payments
$8,413
2024 Payments
$3,958
Companies
31
Transactions
334
Medicare Patients
4,759
Medicare Billing
$456,957

Payment Breakdown by Category

Food & Beverage$6,933 (82.4%)
Other$1,260 (15.0%)
Education$219.89 (2.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,933 330 82.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,260 1 15.0%
Education $219.89 3 2.6%

Top Paying Companies

Company Total Records Latest Year
Incyte Corporation $1,815 12 $0 (2024)
ABBVIE INC. $1,411 85 $0 (2024)
E.R. Squibb & Sons, L.L.C. $847.97 34 $0 (2024)
LEO Pharma Inc. $754.88 33 $0 (2024)
Dermavant Sciences, Inc. $556.62 27 $0 (2024)
Janssen Biotech, Inc. $405.40 24 $0 (2024)
GENZYME CORPORATION $378.45 12 $0 (2024)
Regeneron Healthcare Solutions, Inc. $367.74 14 $0 (2024)
Novartis Pharmaceuticals Corporation $345.22 21 $0 (2024)
PFIZER INC. $303.80 20 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,958 95 Incyte Corporation ($1,756)
2023 $1,513 74 E.R. Squibb & Sons, L.L.C. ($279.31)
2022 $1,728 96 ABBVIE INC. ($457.94)
2021 $1,214 69 AbbVie Inc. ($380.96)

All Payment Transactions

334 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/11/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $21.24 General
Category: Immunology
12/05/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $98.50 General
Category: INFLAMMATION AND IMMUNOLOGY
12/05/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $40.00 General
Category: Immunology
12/05/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Winlevi (Drug) Food and Beverage In-kind items and services $26.26 General
Category: Dermatology
12/04/2024 Incyte Corporation OPZELURA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,260.00 General
Category: Dermatology
12/02/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $16.86 General
Category: DERMATOLOGY
11/26/2024 PFIZER INC. CIBINQO (Drug), LITFULO Food and Beverage In-kind items and services $18.30 General
Category: Inflammation & Immunology
11/20/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $18.90 General
Category: Immunology
11/19/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $14.41 General
11/14/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $18.52 General
Category: Dermatology
11/12/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $18.44 General
Category: IMMUNOLOGY
11/07/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $137.12 General
Category: Dermatology
11/07/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $26.73 General
Category: Dermatology
11/06/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $80.00 General
Category: AESTHETICS AND THERAPEUTICS
10/29/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $28.59 General
Category: AESTHETICS AND THERAPEUTICS
10/29/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $15.16 General
Category: DERMATOLOGY
10/24/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $33.48 General
Category: Immunology
10/16/2024 PFIZER INC. EUCRISA (Drug), CIBINQO, LITFULO Food and Beverage In-kind items and services $13.51 General
Category: DERMATOLOGY
10/16/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $1.42 General
Category: DERMATOLOGY
09/25/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $15.84 General
Category: Immunology
09/24/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $15.70 General
Category: DERMATOLOGY
09/20/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $26.23 General
Category: IMMUNOLOGY
09/17/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Winlevi (Drug) Food and Beverage In-kind items and services $21.41 General
Category: Dermatology
09/09/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $7.73 General
Category: IMMUNOLOGY
09/05/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $31.67 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 18 1,416 2,510 $252,546 $107,634
2022 15 1,061 1,698 $213,360 $99,010
2021 19 1,097 1,765 $265,078 $129,743
2020 18 1,185 2,059 $297,208 $120,570
Total Patients
4,759
Total Services
8,032
Medicare Billing
$456,957
Procedure Codes
70

All Medicare Procedures & Services

70 procedure records from CMS Medicare Utilization — Page 2 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 36 36 $7,807 $3,649 46.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 56 56 $8,133 $3,279 40.3%
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm Office 2022 13 15 $4,054 $1,910 47.1%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 90 388 $3,492 $1,746 50.0%
17111 Destruction of skin growth, 15 or more growths Office 2022 12 18 $3,154 $1,630 51.7%
11103 Biopsy of related skin growth, each additional growth Office 2022 29 42 $2,838 $1,489 52.5%
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm Office 2022 12 13 $4,753 $1,376 28.9%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 27 33 $2,426 $1,053 43.4%
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) Office 2021 36 105 $53,119 $32,689 61.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 196 320 $53,997 $24,539 45.4%
96574 Application of light and light-sensitive drugs following removal of premalignant thickened skin growth, per day Office 2021 34 73 $27,982 $14,218 50.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 167 216 $25,657 $11,875 46.3%
11102 Tangential biopsy of single skin lesion Office 2021 130 168 $23,070 $9,750 42.3%
17110 Destruction of up to 14 skin growths Office 2021 102 115 $17,243 $8,086 46.9%
17000 Destruction of skin growth Office 2021 119 164 $14,254 $5,236 36.7%
13121 Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs Office 2021 12 15 $8,569 $4,150 48.4%
11103 Tangential biopsy of additional skin lesion Office 2021 48 90 $6,255 $3,323 53.1%
17282 Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth Office 2021 19 24 $6,486 $3,166 48.8%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 34 34 $4,949 $2,168 43.8%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 21 21 $4,719 $2,088 44.3%
17262 Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs Office 2021 17 17 $3,987 $1,748 43.8%
17272 Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals Office 2021 15 16 $3,965 $1,715 43.3%
17003 Destruction of 2-14 skin growths Office 2021 81 318 $2,743 $1,375 50.1%
10040 Acne surgery Office 2021 16 16 $2,455 $1,159 47.2%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 27 29 $2,123 $1,091 51.4%

About Brian Cook, P.A.-C

Brian Cook, P.A.-C is a Physician Assistant healthcare provider based in Prosper, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932381696.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Cook, P.A.-C has received a total of $8,413 in payments from pharmaceutical and medical device companies, with $3,958 received in 2024. These payments were reported across 334 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,933).

As a Medicare-enrolled provider, Cook has provided services to 4,759 Medicare beneficiaries, totaling 8,032 services with total Medicare billing of $456,957. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Other Specialties Physician Assistant
  • Location Prosper, TX
  • Active Since 12/04/2007
  • Last Updated 08/20/2013
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1932381696

Products in Payments

  • OPZELURA (Drug) $1,815
  • SKYRIZI (Biological) $870.08
  • DUPIXENT (Biological) $836.14
  • Sotyktu (Drug) $826.58
  • ADBRY (Biological) $596.36
  • VTAMA (Drug) $556.62
  • TREMFYA (Drug) $366.76
  • HUMIRA (Biological) $311.37
  • EUCRISA (Drug) $285.50
  • COSENTYX (Biological) $222.50
  • RINVOQ (Biological) $203.98
  • ENSTILAR (Drug) $158.52
  • Winlevi (Drug) $136.11
  • Klisyri (Drug) $117.60
  • DAXXIFY (Drug) $108.59
  • BLU-U (Medical Supply) $102.26
  • COSENTYX (Drug) $92.50
  • Bimzelx (Biological) $70.39
  • Cimzia (Drug) $64.91
  • TALTZ (Drug) $59.19

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Prosper